NEUROMUSCULAR DISEASES (NMD)
Clinical trials for NEUROMUSCULAR DISEASES (NMD) explained in plain language.
Never miss a new study
Get alerted when new NEUROMUSCULAR DISEASES (NMD) trials appear
Sign up with your email to follow new studies for NEUROMUSCULAR DISEASES (NMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Patient trial hopes to fix rare nerve disease at its genetic root
Disease control OngoingThis study tests a custom-made drug (VCA-894A) in a single person with a rare genetic nerve disease called CMT2S. The drug is designed to correct a specific genetic error and restore a missing protein. The main goals are to check if the treatment is safe and if it can improve mus…
Matched conditions: NEUROMUSCULAR DISEASES (NMD)
Phase: PHASE1, PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New study tests workplace coaching to keep Parkinson's patients on the job
Symptom relief OngoingThis study tests a personalized workplace intervention for 124 Dutch workers with Parkinson's disease, cerebellar ataxia, hereditary spastic paraparesis, or slowly progressive neuromuscular/mitochondrial disorders. A trained facilitator helps employees and their managers identify…
Matched conditions: NEUROMUSCULAR DISEASES (NMD)
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC